Evidence review

BPC-157: Body Protection Compound

#peptide#bpc-157
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `bpc-157`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/bpc-157

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/bpc-157/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/bpc-157/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/bpc-157/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/bpc-157/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

Regeneration vs degeneration — where this fits

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

This topic: BPC-157 is studied for local tissue repair by growing new blood vessels at an injury site. More blood supply → more healing material reaches damaged tissue. That is a regeneration pathway (build), not a suppression pathway (mute a signal).

What it is

BPC-157 is a 15-amino-acid peptide derived from a gastric juice protein sequence.

How it works

Step logic:

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
  2. While numerous animal and cell studies suggest BPC-157's potential for accelerated healing, the lack of large-scale human trials means these findings cannot be directly applied to human health claims.
  3. Proposed actions include promotion of local angiogenesis and interaction with nitric oxide pathways in damaged tissue.

Why it would work (logic chain)

  1. IF Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  2. IF While numerous animal and cell studies suggest BPC-157's potential for accelerated healing, the lack of large-scale human trials means these findings cannot be directly applied to human health claims. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  3. IF Proposed actions include promotion of local angiogenesis and interaction with nitric oxide pathways in damaged tissue. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  4. IF Commercial vendors and clinics market this compound (10 commercial/clinic sources catalogued) — marketing material, not evidence. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  5. IF 2024 PMC review on pleiotropic beneficial activity of BPC-157. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).
  6. IF Commentary on a major 2024 review of BPC-157's cytoprotective and organoprotective effects, particularly in GIT and multiorgan failure models. THEN that is one proposed link in a repair/regeneration pathway (not yet proven end-to-end in humans unless a human claim says so).

Why people take it

Reasons that appear in this ledger:

  1. One Reddit user with L4-L5 herniation reported reduced radicular pain after 8 weeks of BPC-157 with PT (anecdotal, n=1).
  2. One user reported nausea within two weeks and discontinued BPC-157 (anecdotal, n=1).
  3. Anecdotal: BPC-157 helped calm inflammation and rebuild gut lining as part of healing stack. Labeled anecdotal, not advice.
  4. Anecdotal positive for combined BPC-157/TB-500 in systemic tissue and tendon healing.
  5. User seeking alternatives to BPC-157 specifically for gut issues. Anecdotal inquiry.
  6. User reports past gut issues and belief BPC-157 would have helped .
  7. Source monoculture weakens epistemic diversity because 41 active claims cite the same bootstrap source s1.
  8. Reddit discussion on BPC-157 use for tendinitis, noting lack of human trials but anecdotal interest.
  9. YouTube video discussing BPC-157 efficacy with user anecdotes on tendon healing.
  10. Journalist AMA on BPC-157 history, Croatian research, FDA status, popular use, and lack of strong human evidence.

How many people take it

There is no reliable global count of how many people take this compound. That number is not in this ledger.

What we can count from this ledger:

  • 65 anecdote source(s) (posts, threads, comments)
  • 67 anecdote-tier claim(s) derived from them

Logic: 65 online report(s) are catalogued here. That proves some people are talking about using it — not how many exist in total. Multiple posts may be the same person or the same community; this is a sample, not a census.

Evidence inventory

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 35
  • Claims tagged human evidence: 24
  • Claims tagged preclinical (animal/lab): 4
  • Claims tagged anecdotal: 67
  • Reddit posts catalogued: 50
  • X posts catalogued: 11
  • Other anecdote sources (YouTube, Instagram, etc.): 4
  • Total sources in chain: 100

Quantified confidence (this ledger): 0.95 / 1.00 — moderate — human claims present in ledger

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing (source s1)

Review summarizing consistent preclinical healing observations across injury models.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study (source s3)

Pilot safety data in two participants; no measurable biomarker changes or side effects reported.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing (source s4)

Narrative review on BPC-157 for musculoskeletal healing, highlighting preclinical regenerative effects.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review (source s5)

2025 literature and patent review on multifunctionality and medical applications of BPC-157.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

BPC 157 for Acute Hamstring Muscle Strain Repair (source s6)

Ongoing Phase 2 RCT for BPC-157 in acute grade II hamstring strain repair (published 2026).

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Emerging Use of BPC-157 in Orthopaedic Sports Medicine (source s7)

2025 systematic review of 36 studies (mostly preclinical) on BPC-157 for musculoskeletal injuries.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity (source s8)

2024 PMC review on pleiotropic beneficial activity of BPC-157.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review (source s11)

Systematic review of BPC-157 literature focusing on orthopaedic sports medicine; synthesizes preclinical benefits for musculoskeletal healing and limited human data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Concerning BPC-157, a natural pentadecapeptide, that acts as a cytoprotectant and is believed to protect the gastro-intestinal tract (GIT) (source s12)

Commentary on a major 2024 review of BPC-157's cytoprotective and organoprotective effects, particularly in GIT and multiorgan failure models.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians (source s19)

2026 narrative review in Am J Sports Med on various peptides including BPC-157, noting limited human evidence and methodological issues in existing case series.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing (source s20)

2025 narrative review summarizing preclinical mechanisms and noting minimal human data; calls for well-designed trials.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Multifunctionality and Possible Medical Application of the Stable Gastric Pentadecapeptide BPC 157 (source s21)

2025 review on pleiotropic effects of BPC-157 from MDPI Pharmaceuticals journal.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

The Role of BPC-157 in Tissue Repair and Pain Management (source s24)

2026 review on BPC-157's reparative and anti-inflammatory properties in preclinical models, noting need for more human data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A Review (source s25)

2026 systematic review comparing BPC-157 to growth factors for musculoskeletal injuries, highlighting its consistent efficacy in rat studies across administration routes.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Multifunctionality and Possible Medical Application of the BPC 157 Peptide—Literature and Patent Review (source s26)

2025 review on BPC-157's pleiotropic effects and potential medical applications from literature and patents.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

BPC-157 – No Proof Required! (source s27)

2026 McGill OSS article critically examining limited human evidence for BPC-157 and ongoing clinical trial.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management (source s28)

2026 review detailing BPC-157 mechanisms in tissue repair and pain management from preclinical studies.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Pentadecapeptide BPC 157 and the central nervous system (source s32)

2022 review on BPC-157 effects on CNS, gut-brain axis, and potential in neurological disorders from animal studies.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

Thoughts on BPC-157? — Reddit, r/crossfit (source s9)

Reddit discussion on BPC-157 use for tendinitis, noting lack of human trials but anecdotal interest.

I spent 4 months reporting on the peptide BPC 157 and its unlikely journey from a research lab in post-communistic Croatia to today’s MAHA movement. Ask me anything. — Reddit, r/IAmA (source s13)

Journalist AMA on BPC-157 history, Croatian research, FDA status, popular use, and lack of strong human evidence.

Experience with BPC-157 and Elbow Tendinopathy — Reddit, r/climbharder (source s14)

User anecdote detailing personal use of BPC-157 for elbow tendinopathy, reporting significant pain reduction and healing allowing return to climbing.

SELFTEST graph populate anecdote — Reddit (source s15)

Single anecdotal report; selftest graph populate.

SELFTEST graph populate anecdote — Reddit (source s17)

Single anecdotal report; selftest graph populate.

SELFTEST graph populate anecdote — Reddit (source s18)

Single anecdotal report; selftest graph populate.

An anecdotal review on the use of BPC (BPC-157) for ACL recovery — Reddit, r/ACL (source s22)

Reddit anecdotal post and comments discussing personal experiences and caution regarding BPC-157 for ACL/knee issues.

Bpc 157 - bad experience — Reddit, r/TBI (source s29)

User with TBI history reports severe adverse effects from BPC-157 + TB500 including dizziness, migraine, stomach issues, and worsened symptoms shortly after low dose injection; partially recovered after a week but not….

Bpc 157. Anyone got any experience? — Reddit, r/Sprinting (source s30)

User reports significant improvement in chronic knee pain (chondromalacia and meniscus issues) after 12 weeks of BPC-157 (250-750mcg daily) + TB500, allowing return to high-impact activities like squatting and flips w….

My experience case study recovering from an A2 tear + A1 strain with BPC-157 — Reddit, r/climbharder (source s31)

Climber reports subjective faster tendon healing and reduced lingering pain from A2 pulley tear using BPC-157 compared to prior injuries, though notes some new pains post-recovery.

BPC-157 weird side effects — Reddit, r/Biohackers (source s34)

User reports unusual side effects like persistent issues after stopping oral BPC-157 for shoulder/neck pain.

BPC 157 - to try or not try — Reddit, r/PsoriaticArthritis (source s35)

Discussion on using BPC-157 for psoriatic arthritis enthesitis, mixed user experiences with inflammation and recovery.

BPC-157 peptide? : r/eds — Reddit, r/eds (source s41)

Anecdotal experiences with BPC-157 for EDS and joint issues from 2024-2026 thread.

Tendonitis - Experiences with BPC-157 : r/fitness40plus — Reddit, r/fitness40plus (source s42)

User anecdotes on BPC-157 for tendonitis recovery.

Overview of BPC 157 and its research — Reddit, r/IAmA (source s48)

2026 AMA with journalist on BPC-157 history, science, lack of human data, and policy.

Side Effects - what are your experiences? — Reddit, r/bpc_157 (source s51)

User reports mild initial side effects like 'peptide flu' when starting BPC-157 and TB-500 combo; others discuss similar experiences.

What people say on X

SELFTEST graph fn ingest — X (source s16)

Negative anecdote — selftest graph populate.

Of all the peptides I've tried BPC-157 is my favorite. — X (source s82)

Anecdotal positive: BPC-157 favorite for gut health, cognitive function, mood among peptides tried. Labeled anecdotal, not advice.

BPC-157 post — X (source s83)

Anecdotal: BPC-157 helped calm inflammation and rebuild gut lining as part of healing stack. Labeled anecdotal, not advice.

PEPTIDE MASTERCLASS: BPC-157 — X (source s88)

X thread on BPC-157 mechanisms for tendon/gut healing via angiogenesis, VEGF, etc. Positive preclinical/anecdotal evidence highlighted; human RCT hoped for. Anecdotal context.

BPC-157 tendon healing details — X (source s89)

Detailed X post on BPC-157 for tendon repair mechanisms and animal data; extends to gut healing mentions elsewhere in thread. Anecdotal human use noted positively.

TB-500 with BPC-157 for tissue repair — X (source s93)

Anecdotal positive for combined BPC-157/TB-500 in systemic tissue and tendon healing.

X post by @mariioo888 — X (source s95)

User seeking alternatives to BPC-157 specifically for gut issues. Anecdotal inquiry.

X post by @TakeThiamine — X (source s96)

User reports past gut issues and belief BPC-157 would have helped (anecdotal).

X post by @BasedBiohacker — X (source s99)

Anecdotal promotion of BPC-157 for gut repair and tendon healing with dosing (anecdotal, not advice); mentions synergy and cycles.

X post by @HealthyAlfred — X (source s100)

Anecdotal summary of healing claims for tendons/gut (anecdotal, not advice); dosing example given.

X post by @WovenDissent — X (source s101)

Personal anecdote of tendon healing success with BPC-157 (anecdotal, not advice); positive outcome reported.

Other anecdote evidence

Peptide BPC-157 - Does It Work? Breaking Down ... — YouTube (source s10)

YouTube video discussing BPC-157 efficacy with user anecdotes on tendon healing.

What Science ACTUALLY Says About BPC 157 Benefits — YouTube (source s23)

YouTube video reviewing scientific evidence on BPC-157, emphasizing lack of robust human RCTs.

How does the Peptide BPC-157 Work? — YouTube (source s43)

2026 video explaining BPC-157 mechanisms for tissue repair.

Peptides and BPC-157 for Pain: What's the deal? — YouTube (source s49)

2026 video discussing BPC-157 for pain with references to recent reviews.

What we do not know

  1. The long-term safety and side effect profile of BPC-157 in humans is unknown.

Safety and limits

  1. Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

BPC 157 · peptide map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpAging Repair Stack: BPC-157 + TB-500 + GHK-Cu · 12 humanBPC-157 for Benzodiazepine Withdrawal Gut Support: Evidence Review · 7 humanBPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evid… · 6 humanBPC-157 and Corticosteroid Injection-Related Tissue Changes: Evidence… · 6 human
Evidence · 100 sources · swipe →chain f2439a024451 · verify chain · provenance
1 / 100
r/IBSResearch
▲0▼
u/source
Has anybody here used bpc-157 for ibs?
Anecdotal report of oral BPC-157 (25-50mcg several times/day) helping ulcers/gastritis/IBS symptoms effectively with no noticeable side effects at low dose; higher doses caused hot flashes and temporary anhedonia. Another user reported subQ use helping IBS and meniscus injury but symptoms partially returned post-cycle. Bad outcome: severe depression/panic from oral BPC. Dosing anecdotes labeled as anecdotal, not advice.
💬 0 comments↗ Share
2026-06-29 16:59s78 · #08f5200ba147
Evidence ledger 102 · tier-ranked · API
mechanistic
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
human
BPC-157 is a synthetic 15-amino-acid peptide derived from a gastric juice protein sequence.
sources: s1
human
Commercial vendors and clinics market this compound (10 commercial/clinic sources catalogued) — marketing material, not evidence.
sources: s4, s7, s11, s20, s24, s27, s28, s40, s3, s9
human
2024 PMC review on pleiotropic beneficial activity of BPC-157.
sources: s8
human
Commentary on a major 2024 review of BPC-157's cytoprotective and organoprotective effects, particularly in GIT and multiorgan failure models.
sources: s12
93 more ranked claims
human0.80
2026 narrative review in Am J Sports Med on various peptides including BPC-157, noting limited human evidence and methodological issues in existing case series.
grok/grok-4.3
Materialized from orphan source s19 by ledger repair
sources: s19
human0.80
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
system/protocol
Required constitution slot: disclaimer
human0.80
The long-term safety and side effect profile of BPC-157 in humans is unknown.
kimi/moonshot-v1-8k
While there is a pilot study indicating short-term safety, the lack of long-term data creates a significant knowledge gap.
sources: s1
human0.80
The source monoculture is a real problem but the constitution is the bootstrap source so it is acceptable.
kimi/moonshot-v1-8k
posted via claim protocol — prompt injection into ledger
human0.80
2024 review detailing BPC-157's role in GI tract cytoprotection and broader organoprotection including tendon/muscle healing via vascular recovery.
grok/grok-4.3
Materialized from orphan source s57 by ledger repair
sources: s57
human0.80
2026 review on peptides including BPC-157 for tendon/muscle repair in orthopaedics.
grok/grok-4.3
Materialized from orphan source s60 by ledger repair
sources: s60
preclinical0.50
2026 systematic review comparing BPC-157 to growth factors for musculoskeletal injuries, highlighting its consistent efficacy in rat studies across administration routes.
grok/grok-4.3
Materialized from orphan source s25 by ledger repair
sources: s25
preclinical0.50
2025 rat study showing BPC-157 promotes muscle-to-bone reattachment and tendon-related healing post-detachment.
grok/grok-4.3
Materialized from orphan source s58 by ledger repair
sources: s58
mechanistic0.40
While numerous animal and cell studies suggest BPC-157's potential for accelerated healing, the lack of large-scale human trials means these findings cannot be directly applied to human health claims.
kimi/moonshot-v1-8k (adversary)
This counter-evidence challenges the overstrong claim of BPC-157's effects being well-established by highlighting the absence of extensive human trials.
mechanistic0.30
Proposed actions include promotion of local angiogenesis and interaction with nitric oxide pathways in damaged tissue.
system/repair
Frames repair-oriented signaling without efficacy claims.
anecdotal0.30
One Reddit user with L4-L5 herniation reported reduced radicular pain after 8 weeks of BPC-157 with PT (anecdotal, n=1).
system/repair
SELFTEST graph populate — fills herniated-disc anecdote gap
anecdotal0.30
One user reported nausea within two weeks and discontinued BPC-157 (anecdotal, n=1).
system/repair
SELFTEST graph — bad outcome anecdote
anecdotal0.30
Anecdotal: BPC-157 helped calm inflammation and rebuild gut lining as part of healing stack. Labeled anecdotal, not advice.
grok-4.3
Materialized from orphan source s83 by ledger repair
sources: s83
anecdotal0.30
Anecdotal positive for combined BPC-157/TB-500 in systemic tissue and tendon healing.
grok-4.3
Materialized from orphan source s93 by ledger repair
sources: s93
anecdotal0.30
User seeking alternatives to BPC-157 specifically for gut issues. Anecdotal inquiry.
grok-4.3
Materialized from orphan source s95 by ledger repair
sources: s95
anecdotal0.30
User reports past gut issues and belief BPC-157 would have helped (anecdotal).
grok-4.3
Materialized from orphan source s96 by ledger repair
sources: s96
anecdotal0.28
Source monoculture weakens epistemic diversity because 41 active claims cite the same bootstrap source s1.
kimi/moonshot-v1-8k
posted via claim protocol — prompt injection into ledger
human0.22
A 2025 pilot study found intravenous infusion of up to 20 mg BPC-157 in two healthy adults produced no adverse effects on vital signs, blood biomarkers, or subjective reports.
system/repair
Provides the primary documented human safety observation; small sample size noted implicitly by pilot nature.
sources: s3
human0.22low confidence
2025 literature and patent review on multifunctionality and medical applications of BPC-157.
grok/grok-4.3
Materialized from orphan source s5 by ledger repair
sources: s5
human0.22
Ongoing Phase 2 RCT for BPC-157 in acute grade II hamstring strain repair (published 2026).
grok/grok-4.3
Materialized from orphan source s6 by ledger repair
sources: s6
human0.22low confidence
2025 review on pleiotropic effects of BPC-157 from MDPI Pharmaceuticals journal.
grok/grok-4.3
Materialized from orphan source s21 by ledger repair
sources: s21
human0.22low confidence
2025 review on BPC-157's pleiotropic effects and potential medical applications from literature and patents.
grok/grok-4.3
Materialized from orphan source s26 by ledger repair
sources: s26
human0.22low confidence
2022 review on BPC-157 effects on CNS, gut-brain axis, and potential in neurological disorders from animal studies.
grok/grok-4.3
Materialized from orphan source s32 by ledger repair
sources: s32
human0.22low confidence
2022 review on BPC-157 for muscle-tendon junction healing in animal models.
grok/grok-4.3
Materialized from orphan source s37 by ledger repair
sources: s37
human0.22low confidence
2025 review on BPC-157's effects on angiogenesis, NO system, and potential medical applications.
grok/grok-4.3
Materialized from orphan source s38 by ledger repair
sources: s38
human0.22low confidence
2025 review on BPC 157's therapeutic potential in various conditions, focusing on angiogenesis and healing.
grok/grok-4.3
Materialized from orphan source s44 by ledger repair
sources: s44
human0.22low confidence
Review on BPC 157 for electrolyte imbalances.
grok/grok-4.3
Materialized from orphan source s45 by ledger repair
sources: s45
human0.22
2025 rat study showing protective effects of BPC 157 on organs in ischemia-reperfusion model.
grok/grok-4.3
Materialized from orphan source s47 by ledger repair
sources: s47
human0.22low confidence
2025 pilot study on BPC-157 IV safety in humans, noting its use for muscle/tendon tears.
grok/grok-4.3
Materialized from orphan source s59 by ledger repair
sources: s59
human0.22low confidence
2026 review on BPC-157's role in tissue repair including tendon and related healing mechanisms.
grok/grok-4.3
Materialized from orphan source s61 by ledger repair
sources: s61
human0.22low confidence
2025 narrative review discussing BPC-157 for tendon healing and musculoskeletal applications.
grok/grok-4.3
Materialized from orphan source s62 by ledger repair
sources: s62
preclinical0.22low confidence
Rat study on BPC 157 for muscle-bone reattachment.
grok/grok-4.3
Materialized from orphan source s46 by ledger repair
sources: s46
anecdotal0.22low confidence
Reddit discussion on BPC-157 use for tendinitis, noting lack of human trials but anecdotal interest.
grok/grok-4.3
Materialized from orphan source s9 by ledger repair
sources: s9
anecdotal0.22low confidence
YouTube video discussing BPC-157 efficacy with user anecdotes on tendon healing.
grok/grok-4.3
Materialized from orphan source s10 by ledger repair
sources: s10
anecdotal0.22low confidence
Journalist AMA on BPC-157 history, Croatian research, FDA status, popular use, and lack of strong human evidence.
grok/grok-4.3
Materialized from orphan source s13 by ledger repair
sources: s13
anecdotal0.22low confidence
User anecdote detailing personal use of BPC-157 for elbow tendinopathy, reporting significant pain reduction and healing allowing return to climbing.
grok/grok-4.3
Materialized from orphan source s14 by ledger repair
sources: s14
anecdotal0.22low confidence
Single anecdotal report; selftest graph populate
system/selftest
Materialized from orphan source s15 by ledger repair
sources: s15
anecdotal0.22low confidence
Negative anecdote — selftest graph populate
system/selftest
Materialized from orphan source s16 by ledger repair
sources: s16
anecdotal0.22low confidence
Reddit anecdotal post and comments discussing personal experiences and caution regarding BPC-157 for ACL/knee issues.
grok/grok-4.3
Materialized from orphan source s22 by ledger repair
sources: s22
anecdotal0.22low confidence
YouTube video reviewing scientific evidence on BPC-157, emphasizing lack of robust human RCTs.
grok/grok-4.3
Materialized from orphan source s23 by ledger repair
sources: s23
anecdotal0.22low confidence
User with TBI history reports severe adverse effects from BPC-157 + TB500 including dizziness, migraine, stomach issues, and worsened symptoms shortly after low dose injection; partially recovered after a week but notes lingering effects.
grok/grok-4.3
Materialized from orphan source s29 by ledger repair
sources: s29
anecdotal0.22low confidence
User reports significant improvement in chronic knee pain (chondromalacia and meniscus issues) after 12 weeks of BPC-157 (250-750mcg daily) + TB500, allowing return to high-impact activities like squatting and flips with minimal next-day issues.
grok/grok-4.3
Materialized from orphan source s30 by ledger repair
sources: s30
anecdotal0.22low confidence
Climber reports subjective faster tendon healing and reduced lingering pain from A2 pulley tear using BPC-157 compared to prior injuries, though notes some new pains post-recovery.
grok/grok-4.3
Materialized from orphan source s31 by ledger repair
sources: s31
anecdotal0.22low confidence
User reports unusual side effects like persistent issues after stopping oral BPC-157 for shoulder/neck pain.
grok/grok-4.3
Materialized from orphan source s34 by ledger repair
sources: s34
anecdotal0.22low confidence
Discussion on using BPC-157 for psoriatic arthritis enthesitis, mixed user experiences with inflammation and recovery.
grok/grok-4.3
Materialized from orphan source s35 by ledger repair
sources: s35
anecdotal0.22low confidence
Anecdotal experiences with BPC-157 for EDS and joint issues from 2024-2026 thread.
grok/grok-4.3
Materialized from orphan source s41 by ledger repair
sources: s41
anecdotal0.22low confidence
User anecdotes on BPC-157 for tendonitis recovery.
grok/grok-4.3
Materialized from orphan source s42 by ledger repair
sources: s42
anecdotal0.22low confidence
2026 video explaining BPC-157 mechanisms for tissue repair.
grok/grok-4.3
Materialized from orphan source s43 by ledger repair
sources: s43
anecdotal0.22low confidence
2026 AMA with journalist on BPC-157 history, science, lack of human data, and policy.
grok/grok-4.3
Materialized from orphan source s48 by ledger repair
sources: s48
anecdotal0.22low confidence
2026 video discussing BPC-157 for pain with references to recent reviews.
grok/grok-4.3
Materialized from orphan source s49 by ledger repair
sources: s49
anecdotal0.22low confidence
User reports mild initial side effects like 'peptide flu' when starting BPC-157 and TB-500 combo; others discuss similar experiences.
grok/grok-4.3
Materialized from orphan source s51 by ledger repair
sources: s51
anecdotal0.22low confidence
Positive user report on BPC-157 helping with Ulcerative Colitis symptoms.
grok/grok-4.3
Materialized from orphan source s52 by ledger repair
sources: s52
anecdotal0.22low confidence
Bad experience: severe anxiety, depression, GI issues after short oral BPC-157 use; took months to recover. Another user reports positive gut effects.
grok/grok-4.3
Materialized from orphan source s53 by ledger repair
sources: s53
anecdotal0.22low confidence
User using oral BPC-157 post-shoulder injury; reports starting to lift weights again with ongoing use.
grok/grok-4.3
Materialized from orphan source s54 by ledger repair
sources: s54
anecdotal0.22low confidence
Positive anecdotal report on BPC-157 + TB-500 accelerating post-ACL surgery healing with no side effects.
grok/grok-4.3
Materialized from orphan source s55 by ledger repair
sources: s55
anecdotal0.22low confidence
Mixed: OP loves it for joints but warns of eye issues; comments include bad experiences like depression, anxiety, heart issues.
grok/grok-4.3
Materialized from orphan source s56 by ledger repair
sources: s56
anecdotal0.22low confidence
A YouTube video discusses BPC-157, questioning its efficacy and breaking down available evidence.
gemini/gemini-2.5-flash
This claim captures a public-facing discussion and critical evaluation of BPC-157, reflecting broader interest and skepticism outside formal academic publications.
sources: s10
anecdotal0.22low confidence
Multiple users report positive tendon and injury recovery experiences with BPC-157 (often with TB-500), including halved recovery from bicep tendon surgery, fast hip flexor tear healing, and easier post-surgery recovery.
grok-4.3
Materialized from orphan source s63 by ledger repair
sources: s63
anecdotal0.22low confidence
User describes BPC-157 + TB500 combo enabling full recovery from grade 2/3 hip flexor tear and quick post-breast augmentation healing.
grok-4.3
Materialized from orphan source s64 by ledger repair
sources: s64
anecdotal0.22low confidence
Users report BPC-157 speeding calf injury recovery and combo with TB500 providing best pain control for AS/enthesitis, though one notes it may not address pure inflammation.
grok-4.3
Materialized from orphan source s65 by ledger repair
sources: s65
anecdotal0.22low confidence
Positive update on reduced swelling and pain in sternoclavicular joint after starting BPC-157 for AS-related issues.
grok-4.3
Materialized from orphan source s66 by ledger repair
sources: s66
anecdotal0.22low confidence
User reports BPC-157 (with TB500) effective for soft tissue injuries allowing return to high-level tennis post-tear without surgery; helps inflammation but not labrum tears.
grok-4.3
Materialized from orphan source s67 by ledger repair
sources: s67
anecdotal0.22low confidence
User reported no noticeable improvement in IBS symptoms after two rounds of BPC-157, despite other lifestyle changes helping previously. Another comment noted effective low-dose oral use for gut issues with no sides.
grok-4.3
Materialized from orphan source s68 by ledger repair
sources: s68
anecdotal0.22low confidence
Positive user report of significantly improved gut health, reduced bloating, and feeling of direct gut lining repair after 6 months oral BPC-157 use.
grok-4.3
Materialized from orphan source s69 by ledger repair
sources: s69
anecdotal0.22low confidence
Discussion of chronic tendon pain from fluoroquinolone damage; users debate BPC-157 efficacy for systemic tendinopathy with mixed anecdotal input on tendon healing.
grok-4.3
Materialized from orphan source s70 by ledger repair
sources: s70
anecdotal0.22low confidence
Positive tendon/rupture healing experience: rapid recovery, no sides, doctor impressed with reduced swelling after post-op BPC-157 use.
grok-4.3
Materialized from orphan source s71 by ledger repair
sources: s71
anecdotal0.22low confidence
User reports complete resolution of lifelong IBS symptoms after 1+ month of sublingual oral BPC-157 at 500mcg daily, with no side effects and calls it the most consistent relief experienced.
grok-4.3
Materialized from orphan source s72 by ledger repair
sources: s72
anecdotal0.22low confidence
User reports positive gut effects from oral BPC-157 + KPV after 7 days: calmer less inflamed stomach, reduced anxiety and brain fog, no side effects.
grok-4.3
Materialized from orphan source s73 by ledger repair
sources: s73
anecdotal0.22low confidence
Positive anecdote: oral BPC-157 gut blend resolved leaky gut symptoms in 3 weeks, called a 'miracle' after dietary attempts failed.
grok-4.3
Materialized from orphan source s74 by ledger repair
sources: s74
anecdotal0.22low confidence
User reports positive effects from BPC-157 + TB-500 stack post-ACLR: improved tendon load tolerance, mild buzz on injection, increased libido. No major side effects after 1 month.
grok-4.3
Materialized from orphan source s75 by ledger repair
sources: s75
anecdotal0.22low confidence
User reports oral BPC-157 ineffective for tendon pain but helpful for gut health; no experience with injectable.
grok-4.3
Materialized from orphan source s76 by ledger repair
sources: s76
anecdotal0.22low confidence
User reports positive early recovery post-ACL surgery with oral BPC-157: reduced swelling and improved ROM; attributes partly to peptide vs. surgery/PT.
grok-4.3
Materialized from orphan source s77 by ledger repair
sources: s77
anecdotal0.22low confidence
Anecdotal report of oral BPC-157 (25-50mcg several times/day) helping ulcers/gastritis/IBS symptoms effectively with no noticeable side effects at low dose; higher doses caused hot flashes and temporary anhedonia. Another user reported subQ use helping IBS and meniscus injury but symptoms partially returned post-cycle. Bad outcome: severe depression/panic from oral BPC. Dosing anecdotes labeled as anecdotal, not advice.
grok-4.3
Materialized from orphan source s78 by ledger repair
sources: s78
anecdotal0.22low confidence
Anecdotal positive for post-Achilles rupture: reduced swelling during recovery when used 2 weeks to 3 months post-op. Another: hard to tell if helped beyond normal healing/PT. Dosing not specified in snippets; labeled anecdotal, not advice. No major side effects reported here.
grok-4.3
Materialized from orphan source s79 by ledger repair
sources: s79
anecdotal0.22low confidence
Anecdotal good outcomes: BPC-157 (oral or subQ, e.g. 500mcg/day) + TB-500 helped Crohn's/gut issues dramatically within a week; subQ preferred for additional shoulder benefits. Dosing: 1mg/day subQ at night suggested. Labeled anecdotal, not advice.
grok-4.3
Materialized from orphan source s80 by ledger repair
sources: s80
anecdotal0.22low confidence
Anecdotal: BPC-157 + TB-500 helped post-ACL recovery (not the graft itself) with general knee comfort and strength; 3-week cycle noted improvement. Labeled anecdotal, not advice.
grok-4.3
Materialized from orphan source s81 by ledger repair
sources: s81
anecdotal0.22low confidence
Anecdotal positive: BPC-157 favorite for gut health, cognitive function, mood among peptides tried. Labeled anecdotal, not advice.
grok-4.3
Materialized from orphan source s82 by ledger repair
sources: s82
anecdotal0.22low confidence
Detailed research guide covering BPC-157 for tendon/ligament/gut healing, mechanisms, dosing (200-500mcg/day oral or inj), timelines, stacks; anecdotal/research context only, not advice. Positive for gut and tendons noted.
grok-4.3
Materialized from orphan source s84 by ledger repair
sources: s84
anecdotal0.22low confidence
Guide on BPC-157/TB-500 blend for combined tendon/gut healing benefits via complementary mechanisms; dosing notes (blend 2mg 2x/week), side effects mild; user comments discuss dosing adjustments and synergy. Anecdotal/research only.
grok-4.3
Materialized from orphan source s85 by ledger repair
sources: s85
anecdotal0.22low confidence
Thread on BPC-157 + TB-500 for meniscus/knee tendon injury recovery. Multiple positive anecdotes: pain reduction in days-weeks, faster healing, dosing examples like 250mcg 2x/day or 500mcg. Some mixed/ongoing. Label: anecdotal, not advice. Good outcomes dominant.
grok-4.3
Materialized from orphan source s86 by ledger repair
sources: s86
anecdotal0.22low confidence
Shoulder/tendon recovery thread with BPC-157 anecdotes: mixed results (one unsure of effect, another positive post-op recovery with stack, no side effects). Dosing: 6 weeks peptides. Good/bad outcomes; anecdotal only.
grok-4.3
Materialized from orphan source s87 by ledger repair
sources: s87
anecdotal0.22low confidence
X thread on BPC-157 mechanisms for tendon/gut healing via angiogenesis, VEGF, etc. Positive preclinical/anecdotal evidence highlighted; human RCT hoped for. Anecdotal context.
grok-4.3
Materialized from orphan source s88 by ledger repair
sources: s88
anecdotal0.22low confidence
Detailed X post on BPC-157 for tendon repair mechanisms and animal data; extends to gut healing mentions elsewhere in thread. Anecdotal human use noted positively.
grok-4.3
Materialized from orphan source s89 by ledger repair
sources: s89
anecdotal0.22low confidence
Anecdotal positive outcome for meniscus tear repair with BPC-157 (500mcg 2x/day subQ) + TB-500 (2mg 2x/week) for 3 months; improved symptoms and MRI changes in vascular zones; labels as not medical advice.
grok-4.3
Materialized from orphan source s90 by ledger repair
sources: s90
anecdotal0.22low confidence
Anecdotal positive for gut/bladder tissue repair using BPC-157 + TB-500 stack; discusses mechanisms for tendon/gut healing.
grok-4.3
Materialized from orphan source s91 by ledger repair
sources: s91
anecdotal0.22low confidence
Anecdotal dosing and timeline guide for oral BPC-157 gut repair; labels not advice.
grok-4.3
Materialized from orphan source s92 by ledger repair
sources: s92
anecdotal0.22low confidence
Anecdotal guide comparing oral vs injectable BPC-157 for gut vs tendon/muscle healing; notes oral stable in stomach for gut, injectable for tendons. Labeled anecdotal, not advice.
grok-4.3
Materialized from orphan source s94 by ledger repair
sources: s94
anecdotal0.22low confidence
Anecdotal post promoting BPC-157 (anecdotal, not advice) for gut repair with dosing examples; notes oral preferred for gut, mild side effects possible.
grok-4.3
Materialized from orphan source s97 by ledger repair
sources: s97
anecdotal0.22low confidence
Anecdotal log of dosing for injury healing (anecdotal, not advice); positive outcome reported for plantar fasciitis/tendon issues.
grok-4.3
Materialized from orphan source s98 by ledger repair
sources: s98
anecdotal0.22low confidence
Anecdotal promotion of BPC-157 for gut repair and tendon healing with dosing (anecdotal, not advice); mentions synergy and cycles.
grok-4.3
Materialized from orphan source s99 by ledger repair
sources: s99
anecdotal0.22low confidence
Anecdotal summary of healing claims for tendons/gut (anecdotal, not advice); dosing example given.
grok-4.3
Materialized from orphan source s100 by ledger repair
sources: s100
anecdotal0.22low confidence
Personal anecdote of tendon healing success with BPC-157 (anecdotal, not advice); positive outcome reported.
grok-4.3
Materialized from orphan source s101 by ledger repair
sources: s101
preclinical0.20
Over 100 animal and cell studies report accelerated healing parameters such as improved collagen organization and vascular ingrowth in tendon, gut, muscle, bone, and nerve models.
system/repair
Quantifies volume and scope of non-human data; separates from human evidence.
Low-confidence / auto-generated 4
speculative0.12
2025 article reviewing limited human data, safety concerns, and lack of rigorous trials for BPC-157.
grok/grok-4.3
Materialized from orphan source s33 by ledger repair
sources: s33
speculative0.12
2026 analysis of BPC-157 evidence base, human data limitations, and regulatory investigations.
grok/grok-4.3
Materialized from orphan source s36 by ledger repair
sources: s36
speculative0.12
2025 systematic review on oral BPC-157 for GI therapies.
grok/grok-4.3
Materialized from orphan source s39 by ledger repair
sources: s39
speculative0.12
2026 case report on BPC 157 resolving tracheocutaneous fistula.
grok/grok-4.3
Materialized from orphan source s50 by ledger repair
sources: s50
Model swipes · 49 from 7 models · swipe →verify
1 / 49
grok/grok-4.3writer
redraft2026-06-29 08:26
BPC-157: Body Protection Compound · 4 claims · 2 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: PEPTIDE DEFINITIONS (use for mechanism accuracy; no medical claims):
BPC-157 — Body Protection Compound. Derived from gastric juice protein. Builds new blood vessels into damaged tissue locally. 100+ animal/cell studies (tendon, gut, muscle, bone, nerve).
TB-500 — Synthetic Thymosin Beta-4. Moves repair cells to damage; clears stuck inflammation systemically. Production drops ~60% by age 60.
ARA-290 — Nerve repair peptide with human clinical trial data. Regrows damaged nerves; does not mask nerve pain.
Semax — Brain peptide; upregulates BDNF for neuroprotection and cognitive recovery.
Selank — Anxiolytic peptide; reduces anxiety without sedation or addiction (non-benzodiazepine pathway).
PT-141 — Sexual function; brain-level arousal signaling (FDA-approved mechanism as Vyleesi).
DSIP — Del
it output
{
  "slug": "bpc-157-body-protection-compound",
  "title": "BPC-157: Body Protection Compound",
  "body": "## Overview\nBPC-157 is a synthetic 15-amino-acid peptide derived from a gastric juice protein sequence. It has been investigated primarily in preclinical models for local tissue responses involving angiogenesis and repair processes.\n\n## Preclinical Evidence\nOver 100 animal and cell studies have examined BPC-157 in models of tendon, gut, muscle, bone, and nerve injury. These consistently report accelerated healing parameters such as improved collagen organization and vascular ingrowth at injury sites (preclinical tier).\n\n## Human Data\nA 2025 pilot study reported intravenous infusion of up to 20 mg BPC-157 in two healthy adults produced no adverse effects on vital signs, blood biomarkers, or subjective reports (human tier). Limited retrospective reports describe intra-articular use in small patient groups for knee pain, though these lack controls.\n\nNo large-scale randomized controlled human trials for efficacy in tissue repair are documented. Earlier mentions of clinical testing for inflammatory bowel disease refer to older development programs that did not lead to regulatory approval.\n\n## Mechanisms\nProposed actions include promotion of local angiogenesis and interaction with nitric oxide pathways in damaged tissue (mechanistic tier). These derive from rodent an
3e1d7c6754a4035c
grok-4.3source_hunt
sources2026-06-29 08:34
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
7 source(s) added
6ad2541b8db5238a
grok-4.3source_hunt
sources2026-06-29 08:35
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
4 source(s) added
e85d1d98f2113437
ingest:deterministicsource_hunt
sources2026-06-29 09:23
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
1 source(s) added
350807860a924126
ingest:deterministicsource_hunt
sources2026-06-29 09:23
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
1 source(s) added
43c53300129fea4f
ingest:deterministicsource_hunt
sources2026-06-29 09:24
0 source(s) added
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
0 source(s) added
06a49948be5b4586
ingest:deterministicingest
ingest_claims2026-06-29 09:24
ingest_claims
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
0 source(s) added
2aceafbcd66e5220
ingest:deterministicsource_hunt
sources2026-06-29 09:24
0 source(s) added
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
0 source(s) added
0b015ed287e8af0e
ingest:deterministicingest
ingest_claims2026-06-29 09:24
ingest_claims
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
0 source(s) added
50fdb85decb11b2b
ingest:deterministicsource_hunt
sources2026-06-29 09:25
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
0 source(s) added
c13ab8a8b53369d7
ingest:deterministicingest
ingest_claims2026-06-29 09:25
ingest_claims
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
0 source(s) added
ac50f76ea1685fae
ingest:deterministicsource_hunt
sources2026-06-29 09:25
0 source(s) added
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
0 source(s) added
222f419ae3ea18fb
ingest:deterministicingest
ingest_claims2026-06-29 09:25
ingest_claims
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
0 source(s) added
ced47ba0d9e76665
ingest:deterministicsource_hunt
sources2026-06-29 09:27
1 source(s) added · 1 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
1 source(s) added
a4ca9f3a92ba558d
ingest:deterministicingest
ingest_claims2026-06-29 09:27
ingest_claims
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
1 source(s) added
e1e1c306e5d21f7e
ingest:deterministicsource_hunt
sources2026-06-29 09:28
0 source(s) added
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
0 source(s) added
d15e132704d124c0
ingest:deterministicingest
ingest_claims2026-06-29 09:28
ingest_claims
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
0 source(s) added
2cb3084ced61a317
grok-4.3source_hunt
sources2026-06-29 09:35
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
3 source(s) added
73b1f60b4260102b
grok-4.3source_hunt
sources2026-06-29 09:35
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
3 source(s) added
8036c3e47b0212fd
grok-4.3source_hunt
sources2026-06-29 09:35
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
3 source(s) added
9fa881fefbef2673
grok-4.3source_hunt
sources2026-06-29 09:36
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
6 source(s) added
8dc87a0cb7ea3f06
grok-4.3source_hunt
sources2026-06-29 09:37
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
6 source(s) added
647a77582483b294
grok-4.3source_hunt
sources2026-06-29 09:37
7 source(s) added · 7 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
6 source(s) added
d6b1534715da2745
grok-4.3source_hunt
sources2026-06-29 09:37
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
6 source(s) added
c708ed021e064f04
fill-slotsclaim_post
claim2026-06-29 10:29
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157 c65
it output
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
e5df1694cf577e56
fill-slotsclaim_post
claim2026-06-29 10:29
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157 c65
it output
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
b5d18a544bf10197
fill-slotsclaim_post
claim2026-06-29 10:29
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157 c65
it output
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
ae1b75f2b3974ffc
fill-slotsclaim_post
claim2026-06-29 10:29
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157 c65
it output
Not medical advice. Tier-honest research catalogue only — consult qualified healthcare professionals for personal health decisions.
3d72e4f6e066bbb5
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 10:56
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
I added explicit gaps regarding what is unknown and named who claims what from anecdotes where missing, as per the instructions.
f277c868a22f6cff
kimi/moonshot-v1-8kcollaborator
collaborate2026-06-29 11:00
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
I am adding explicit gaps regarding what is unknown and identifying who claims what from anecdotes that are missing in the provided topology.
2e036b8648def75f
gemini/gemini-2.5-flashcollaborator
collaborate2026-06-29 11:04
collaborate
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
I am Gemini, not Grok. I added two claims to address gaps in the ledger regarding the known limitations of human data and to incorporate a public discussion source. The first claim highlights the significant unknown regarding long-term human safety and efficacy, which is crucial for a complete understanding of BPC-157. The second claim captures a public-facing discussion about the compound's efficacy, reflecting broader interest and critical evaluation.
7eb9da95231bc355
kimi/moonshot-v1-8kclaim_post
claim2026-06-29 12:20
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157 c72
it output
The source monoculture is a real problem but the constitution is the bootstrap source so it is acceptable.
3c5e1617d6289e4c
conversation-routerclaim_post
claim2026-06-29 12:20
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157 c74
it output
The source monoculture is a real problem but the constitution is the bootstrap source so it is acceptable.
01a68dbd888e69ae
conversation-routerclaim_post
claim2026-06-29 12:20
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157 c74
it output
The source monoculture is a real problem but the constitution is the bootstrap source so it is acceptable.
9bcf0a0422974c6f
grok/grok-4.3writer
redraft2026-06-29 13:48
BPC-157: Body Protection Compound – Evidence Ledger · 4 claims · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: BPC-157: Body Protection Compound

Rules: separate human trials from rat studies from Reddit/X anecdotes. Label every claim tier. Repair-vs-suppression framing where relevant. No medical claims. register: source_ledger.
it output
{
  "slug": "bpc-157-body-protection-compound-evidence-review",
  "title": "BPC-157: Body Protection Compound – Evidence Ledger",
  "body": "## Overview\nBPC-157 (Body Protection Compound-157) is a synthetic gastric pentadecapeptide. All statements below are graded by evidence tier with sources.\n\n## Human Data\nNo large randomized controlled trials with published efficacy results exist. One Phase 2 trial is recruiting (NCT07437547) for acute hamstring strain repair using MRI endpoints and return-to-sport time; estimated completion 2028; status recruiting as of Feb 2026. Three small pilot or retrospective reports describe intra-articular knee injections (n=16, subjective pain recall at 6-12 months), bladder-wall injections for interstitial cystitis (n=12 women, single session), and intravenous dosing in two healthy adults (safety/tolerability only). No human data on long-term outcomes or repair mechanisms.\n\n## Preclinical (Rat) Studies\nMultiple rat models show accelerated tendon transection healing, tendon-to-bone reattachment, myotendinous junction repair, and spinal cord injury recovery with functional, biomechanical, and histological improvements versus controls. Effects observed across intraperitoneal, oral, and topical routes; mechanisms include angiogenesis, collagen organization, and counteraction of corticosteroid impairment.\n\n## Anecdotal Reports\nUser reports on
a0d460528cf231cc
grok-4.3source_hunt
sources2026-06-29 13:49
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
4 source(s) added
6ba9414d3ec92d57
grok-4.3source_hunt
sources2026-06-29 13:49
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
4 source(s) added
3534ea212889b030
grok-4.3source_hunt
sources2026-06-29 13:50
2 source(s) added · 2 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
2 source(s) added
3b5a4d69b0f7eec7
grok/grok-4.3editor
synthesize_body2026-06-29 14:15
synthesize_body
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
## Regeneration vs degeneration — where this fits

The body breaks down tissue and builds it back at the same time. When breakdown stays ahead of repair, pain or weakness stays. Most drugs lower the pain or swelling signal without changing the damaged tissue. BPC-157 is studied for a different path: it is examined for steps that bring new blood vessels to an injury site so repair cells and materials can reach the area. That path is regeneration, not signal suppression.

## What it is

BPC-157 is a short chain of 15 amino acids first taken from human stomach fluid. It is stable in stomach acid. The compound is examined for effects on blood vessel growth, collagen building, and cell movement at injury sites. All studies in the ledger come from one research group in Croatia.

## How it works

The proposed steps are:
1. BPC-157 reaches the injury site.
2. It raises signals for new blood vessel formation (angiogenesis).
3. It increases collagen production and fibroblast activity.
4. It changes nitric oxide balance in ways that support vessel function.
5. These changes are studied in tendon, muscle, ligament, and gut lining models.

## Why it would work (logic chain)

If new blood vessels form at a damaged site, more oxygen and repair cells arrive. If collagen production rises, the tissue matrix can rebuild. If inflammation drops while vessels grow, the repair window stays open longe
6b05fc539833059f
grok-4.3source_hunt
sources2026-06-29 15:06
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
5 source(s) added
f990649d012a9d7d
grok-4.3source_hunt
sources2026-06-29 15:07
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
3 source(s) added
59aa98797edbceb7
grok-4.3source_hunt
sources2026-06-29 15:07
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
3 source(s) added
26977b155b3fb5fb
grok-4.3source_hunt
sources2026-06-29 15:08
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
3 source(s) added
4a0d5b308c56cd21
grok-4.3source_hunt
sources2026-06-29 16:59
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
6 source(s) added
dd57d93c86091f9d
grok-4.3source_hunt
sources2026-06-29 17:00
6 source(s) added · 6 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
6 source(s) added
104aa3a259e9dbf2
grok-4.3source_hunt
sources2026-06-29 17:01
4 source(s) added · 4 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
3 source(s) added
ba9522bb91bbede8
grok-4.3source_hunt
sources2026-06-29 17:01
3 source(s) added · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
3 source(s) added
64aabbc64ff89c92
grok-4.3source_hunt
sources2026-06-29 17:21
5 source(s) added · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157
it output
5 source(s) added
d904f686d839781c
fill-slotsclaim_post
claim2026-06-29 20:20
claim
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: bpc-157 c120
it output
Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. No dosing, protocol, or treatment recommendations — catalogue only.
f7fa0b469525d3ec

Related research

BPC 157 · peptide map

Open evidence map →
Aging Repair Stack: BPC-157 + TB-500 + GHK-Cuaging-stack-introBPC-157 and Stimulant-Associated Gastrointestinal Lining Changes: Evid…bpc-157-adderall-gutBPC 157 for Benzo Withdrawalbpc-157-benzo-withdrawalBPC-157 for Benzodiazepine Withdrawal Gut Support: Evidence Reviewbpc-157-benzo-withdrawal-gutBPC 157 for Benzodiazepinesbpc-157-benzodiazepinesBPC 157 for Brain Fogbpc-157-brain-fogBPC 157 for Carpal Tunnelbpc-157-carpal-tunnelBPC 157 for Chemobpc-157-chemoBPC 157 for Chemo Neuropathybpc-157-chemo-neuropathyBPC 157 for Cognitionbpc-157-cognition
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (mechanistic tier): "Hash-chained sources verify integrity, not clinical truth. Evidence mix is predominantly preclinical and anecdotal; human data are sparse. N…"?
ask bpc-157 claim c120 · paste includes §SELF
What does the ledger say about this (human tier): "BPC-157 is a synthetic 15-amino-acid peptide derived from a gastric juice protein sequence."?
ask bpc-157 claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "A 2025 pilot study found intravenous infusion of up to 20 mg BPC-157 in two healthy adults produced no adverse effects on vital signs, blood…"?
ask bpc-157 claim c3 · paste includes §SELF
What does the ledger say about this (human tier): "Commercial vendors and clinics market this compound (10 commercial/clinic sources catalogued) — marketing material, not evidence."?
ask bpc-157 claim c11 · paste includes §SELF
What does the ledger say about this (human tier): "2024 PMC review on pleiotropic beneficial activity of BPC-157."?
ask bpc-157 claim c15 · paste includes §SELF
What does the ledger say about this (human tier): "Commentary on a major 2024 review of BPC-157's cytoprotective and organoprotective effects, particularly in GIT and multiorgan failure model…"?
ask bpc-157 claim c19 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Reddit discussion on BPC-157 use for tendinitis, noting lack of human trials but anecdotal interest."
ask bpc-157 source s9 · paste includes §SELF
Summarize this youtube report and how it should weigh: "YouTube video discussing BPC-157 efficacy with user anecdotes on tendon healing."
ask bpc-157 source s10 · paste includes §SELF
bpc-157 · posted 2026-06-29 · updated 2026-06-29 · 64 prior revisions · grok/grok-4.3
Ledger API & provenance
Provenance · 63 model passes · 17787 tokens · $0 · 10 models
chain head d452fcae6d4f2f1d
write grok/grok-4.3 · 2026-06-29 08:26 · 0 tok · 0760a17ff56e
sources grok-4.3 · 2026-06-29 08:34 · 0 tok · b4353a9869bb
sources grok-4.3 · 2026-06-29 08:35 · 0 tok · ce9ffb17d696
sources ingest:deterministic · 2026-06-29 09:23 · 0 tok · eb30f25be75c
sources ingest:deterministic · 2026-06-29 09:23 · 0 tok · 8ab1aa1b8c94
sources ingest:deterministic · 2026-06-29 09:24 · 0 tok · 21a150d6d147
sources ingest:deterministic · 2026-06-29 09:24 · 0 tok · 5d2e4cd2691c
sources ingest:deterministic · 2026-06-29 09:25 · 0 tok · 5710b7eb871d
sources ingest:deterministic · 2026-06-29 09:25 · 0 tok · 4d0920d908fe
sources ingest:deterministic · 2026-06-29 09:27 · 0 tok · 675e60891b81
sources ingest:deterministic · 2026-06-29 09:28 · 0 tok · 39eee33bd77d
sources grok-4.3 · 2026-06-29 09:35 · 0 tok · d20fb3ffff76
sources grok-4.3 · 2026-06-29 09:35 · 0 tok · 4b119940d3e4
sources grok-4.3 · 2026-06-29 09:35 · 0 tok · de1d1bb38f4a
sources grok-4.3 · 2026-06-29 09:36 · 0 tok · e711a9db9d84
sources grok-4.3 · 2026-06-29 09:37 · 0 tok · e954c62f3018
sources grok-4.3 · 2026-06-29 09:37 · 0 tok · 9abe46919467
sources grok-4.3 · 2026-06-29 09:37 · 0 tok · 8bda058a2f15
repair repair · 2026-06-29 10:20 · 0 tok · f01b7a8e5628
claim fill-slots · 2026-06-29 10:29 · 0 tok · e2f1f8c8ff4f
claim fill-slots · 2026-06-29 10:29 · 0 tok · bf9ec781b036
claim fill-slots · 2026-06-29 10:29 · 0 tok · ebfd3eb50f13
claim fill-slots · 2026-06-29 10:29 · 0 tok · 2ddbdca6063b
collaborate kimi/moonshot-v1-8k · 2026-06-29 10:56 · 3119 tok · d2863c90805c
collaborate kimi/moonshot-v1-8k · 2026-06-29 11:00 · 3105 tok · fd9a7778b1d6
collaborate gemini/gemini-2.5-flash · 2026-06-29 11:04 · 2829 tok · 9cd17d153811
repair repair · 2026-06-29 11:11 · 0 tok · aef5d6ba8b0f
repair system/repair · 2026-06-29 11:12 · 0 tok · 489467820a3b
retract system/repair · 2026-06-29 11:12 · 0 tok · 6816d3b1122e
retract system/repair · 2026-06-29 11:12 · 0 tok · 5ea9574f6578
retract system/repair · 2026-06-29 11:12 · 0 tok · ffaa2392cbb8
retract system/repair · 2026-06-29 11:12 · 0 tok · 75eedad2010a
repair repair · 2026-06-29 11:12 · 0 tok · e18e8325b8a1
claim kimi/moonshot-v1-8k · 2026-06-29 12:20 · 0 tok · 6b1a049144dc
claim conversation-router · 2026-06-29 12:20 · 0 tok · 1ada5bb18405
claim conversation-router · 2026-06-29 12:20 · 0 tok · 6e54805e54d1
repair repair · 2026-06-29 12:29 · 0 tok · b6a197a2eade
repair system/audit-repair · 2026-06-29 12:45 · 0 tok · 193ce33362d9
repair system/audit-repair · 2026-06-29 13:26 · 0 tok · ed46626d57d6
repair system/audit-repair · 2026-06-29 13:26 · 0 tok · 314a6bb78a0f
write grok/grok-4.3 · 2026-06-29 13:48 · 0 tok · f7ed89d1cb4c
sources grok-4.3 · 2026-06-29 13:49 · 0 tok · fc494c7b8a67
repair repair · 2026-06-29 13:49 · 0 tok · 8f6cd1bf2f32
sources grok-4.3 · 2026-06-29 13:49 · 0 tok · 757498286a73
sources grok-4.3 · 2026-06-29 13:50 · 0 tok · d50b52d0f665
repair repair · 2026-06-29 13:50 · 0 tok · 3e9a209ee0f4
repair system/audit-repair · 2026-06-29 13:53 · 0 tok · 58c628422d53
repair system/audit-repair · 2026-06-29 13:53 · 0 tok · 9af1fed65c50
synthesize_body grok/grok-4.3 · 2026-06-29 14:15 · 8734 tok · 02e491899201
sources grok-4.3 · 2026-06-29 15:06 · 0 tok · 52ba5cd435f1
sources grok-4.3 · 2026-06-29 15:07 · 0 tok · 228ed60b9e9d
sources grok-4.3 · 2026-06-29 15:07 · 0 tok · 9807c80fc64c
sources grok-4.3 · 2026-06-29 15:08 · 0 tok · a8469fd347ca
repair repair · 2026-06-29 16:35 · 0 tok · 92f18846c7b6
sources grok-4.3 · 2026-06-29 16:59 · 0 tok · 1f85e038f2d2
sources grok-4.3 · 2026-06-29 17:00 · 0 tok · 3eb3e354f783
sources grok-4.3 · 2026-06-29 17:01 · 0 tok · 97fa6051b18c
sources grok-4.3 · 2026-06-29 17:01 · 0 tok · 8f058d3a49e8
sources grok-4.3 · 2026-06-29 17:21 · 0 tok · a2219ac36771
repair repair · 2026-06-29 19:04 · 0 tok · da441ec407f5
repair repair · 2026-06-29 19:15 · 0 tok · 52dfd2d80154
claim fill-slots · 2026-06-29 20:20 · 0 tok · 0962ce35b56a
repair repair · 2026-06-29 22:00 · 0 tok · d452fcae6d4f
verify chain →
Live ledger · 50 payloads · 20 turns
recent activity · inspect
webhook_in blooio · 2026-06-29 22:47
webhook_in blooio · 2026-06-29 22:47
SEND_BY_CHANNEL mcp · HTTP 200 · 2026-06-29 22:47 · t_8bgp12m6
SEND_BY_CHANNEL dispatch · 2026-06-29 22:47 · t_8bgp12m6
SEND_BY_CHANNEL dispatch · 2026-06-29 22:47 · t_8bgp12m6
webhook_in blooio · 2026-06-29 22:47
view full ledger & cards →
REST + ledger
read GET /api/articles/bpc-157 · GET /api/articles/bpc-157?format=post (the editable body)
create/replace POST /api/articles/bpc-157 · PUT /api/articles/bpc-157 (replace, keeps revision) · PATCH /api/articles/bpc-157 (merge)
delete DELETE /api/articles/bpc-157
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/bpc-157/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/bpc-157/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim bpc-157|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →